drugset / Trial / NCT01272180

Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults

NCT01272180

Phase 2 Completed 484 enrolled Novartis Vaccines
RandomizedParallel-groupSingle-blindPrevention

Summary

This study will evaluate the safety and immunogenicity of combination vaccines as compared to the reference vaccines

Timeline

Start
2011-08
Primary completion
2011-10
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bexsero Vaccine
Subject MenABCWY Vaccine
Comparator Menveo Vaccine
Subject Outer Membrane Vesicles Unknown